Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
by
Reaman, Gregory H.
in
Alara Concept in Pediatric Imaging: Oncology
/ Child
/ Clinical Trials as Topic
/ Diagnostic Imaging - standards
/ Humans
/ Imaging
/ Medicine
/ Medicine & Public Health
/ Neoplasms - diagnosis
/ Neoplasms - therapy
/ Neuroradiology
/ Nuclear Medicine
/ Oncology
/ Pediatrics
/ Practice Guidelines as Topic
/ Radiology
/ Treatment Outcome
/ Ultrasound
2009
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
by
Reaman, Gregory H.
in
Alara Concept in Pediatric Imaging: Oncology
/ Child
/ Clinical Trials as Topic
/ Diagnostic Imaging - standards
/ Humans
/ Imaging
/ Medicine
/ Medicine & Public Health
/ Neoplasms - diagnosis
/ Neoplasms - therapy
/ Neuroradiology
/ Nuclear Medicine
/ Oncology
/ Pediatrics
/ Practice Guidelines as Topic
/ Radiology
/ Treatment Outcome
/ Ultrasound
2009
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
by
Reaman, Gregory H.
in
Alara Concept in Pediatric Imaging: Oncology
/ Child
/ Clinical Trials as Topic
/ Diagnostic Imaging - standards
/ Humans
/ Imaging
/ Medicine
/ Medicine & Public Health
/ Neoplasms - diagnosis
/ Neoplasms - therapy
/ Neuroradiology
/ Nuclear Medicine
/ Oncology
/ Pediatrics
/ Practice Guidelines as Topic
/ Radiology
/ Treatment Outcome
/ Ultrasound
2009
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
Journal Article
What, why, and when we image: considerations for diagnostic imaging and clinical research in the Children’s Oncology Group
2009
Request Book From Autostore
and Choose the Collection Method
Overview
Success in improving treatment outcomes in childhood cancer has been achieved almost exclusively through multicenter and multidisciplinary clinical and applied research over several decades. While biologically rational as well as empirical approaches have led to combination chemotherapy and multimodality approaches to therapy, which have given rise to evidence-based practice standards, similar scientific rigor has not always been as evidently applied to modalities utilized to assess initial disease burden and, more important, response to investigational approaches to therapy. As the empirical approach to therapeutic advances has likely maximized its benefit, future progress will require translation of biologic discovery most notably from the areas of genomics and proteomics. Hence, attempts to improve efficacy of therapy will require a parallel effort to minimize collateral damage of future therapeutic approaches, and such a parallel approach will mandate the continued dependence on advances in diagnostic imaging for improvements in staging methodologies to best define risk groups for risk-adjusted therapy. In addition, anatomic and functional assessment of response and surveillance for disease recurrence will require improved understanding of the biology as well as natural history of individual diseases, which one hopes will better inform investigators in designing trials. Clinical and research expertise is urgently needed in the selection of specific imaging studies and frequencies that best assess a response as well as to define disease-free intervals. Despite limited resources to develop sufficient infrastructure, emphasis on enabling early assessment of new technology to minimize risks associated with treatment advances and with those critical diagnostic and staging procedures must continue to be a focus of pediatric cancer clinical research.
Publisher
Springer-Verlag,Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.